Shenling Baizhu San improves functional dyspepsia in rats as revealed by 1H-NMR based metabolomics

• Published in: Analytical methods 2020-01, Vol.12 (18), p.2363-2375
• Main Authors: Zhang, Shaobao, Xu, Zengmei, Cao, Xueqing, Xie, Yuzhen, Lin, Lei, Zhang, Xiao, Zou, Baorong, Liu, Deliang, Cai, Ying, Liao, Qiongfeng, Xie, Zhiyong
• Format: Article
• Language: English
• Subjects: Absorptivity; Amino acids; Appetite loss; Chain branching; Choline; Citric acid; Data analysis; Dyspepsia; Energy metabolism; Gastric motility; Gastrointestinal diseases; Herbal medicine; Intestinal microflora; Metabolic disorders; Metabolic pathways; Metabolism; Metabolomics; Microbiota; Multivariate analysis; NMR; Nuclear magnetic resonance; Pyruvic acid; Signs and symptoms; Spectroscopy; Taurine; Traditional Chinese medicine; Trimethylamine; Weight loss
• ISSN: 1759-9660; 1759-9679
• DOI: 10.1039/d0ay00580k

Functional dyspepsia (FD), a common gastrointestinal disorder around the world, is driven by multiple factors, making prevention and treatment a major challenge. Shenling Baizhu San (SBS), a classical prescription of traditional Chinese medicine, has been proven to be effective in gastrointestinal disorders. However, studies on SBS improving FD are few. Thus, our study aimed to evaluate the effect of SBS on FD and further to explore the mechanism underlying the interactions between FD and SBS by the metabolomics approach. A FD rat model was induced by multiple forms of mild stimulation, and proton nuclear magnetic resonance (1H-NMR) spectroscopy and multivariate data analysis were used to profile the fecal and urinary metabolome in the FD rats during SBS intervention. Significant dyspeptic symptoms such as weight loss, poor appetite, reduced gastrointestinal motility and decreased absorptive capacity were observed in the FD rats, which were subsequently improved by SBS. Additionally, the levels of citrate, branched chain acids and pyruvate decreased, and the levels of choline, trimethylamine and taurine increased in the FD rats. Furthermore, the metabolic disorders were amended with SBS intervention mainly by modulating the metabolic pathways involved in energy metabolism, amino acid metabolism, and gut microbiota and host co-metabolism. Overall, our study highlighted the effect of SBS on the disturbed metabolic pathways in the FD rats, providing new insight into the mechanism of SBS treatment for FD from the perspective of metabolomics.